| PC group | RC group | P value |
---|---|---|---|
Operation time(min) | 169.50(130.00~225.25) | 420.00(343.75~483.75) | P<0.001 |
Intraoperative bleeding(ml) | 100(50~100) | 400(200~1000) | P<0.001 |
Blood transfusion quantity(ml) | 0(0~0) | 600(150.00~906.25) | P<0.001 |
Blood transfusion treatment(%) | 5(15.6%) | 53(75.7%) | P<0.001 |
Total length of stay(day) | 18(14.25~20.00) | 24.5(20.00~34.25) | P<0.001 |
Pre-operative hospital stay(day) | 7(4.25~8.00) | 10(8.00~13.00) | P<0.001 |
Postoperative hospital stay(day) | 9(8.00~13.50) | 14(11.00~21.25) | P<0.001 |
Surgical complications(%) | 28.1%(9/32) | 50.0%(35/70) | 0.033 |
30-day complication rate, (%) | Â | Â | Â |
surgical site infections | 9.4%(3/32) | 10%(7/70) | 1.000 |
Perioperative deaths(%) | 0 | 2(2.9%) | 1.000 |
Recurrence or distant metastasis(%) | 40.0%(12/30) | 25.4%(16/63) | 0.151 |
Bladder cancer-specific death(%) | 33.3%(10/30) | 22.2%(14/63) | 0.219 |